BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19478132)

  • 1. Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamster.
    King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Zhao G; Mittelstadt SW; Cox BF
    J Pharmacol Exp Ther; 2009 Aug; 330(2):526-31. PubMed ID: 19478132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo efficacy of acyl CoA: diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemia.
    King AJ; Segreti JA; Larson KJ; Souers AJ; Kym PR; Reilly RM; Collins CA; Voorbach MJ; Zhao G; Mittelstadt SW; Cox BF
    Eur J Pharmacol; 2010 Jul; 637(1-3):155-61. PubMed ID: 20385122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased diacylglycerol acyltransferase activity is associated with triglyceride accumulation in tissues of diet-induced insulin-resistant hyperlipidemic hamsters.
    Casaschi A; Maiyoh GK; Adeli K; Theriault AG
    Metabolism; 2005 Mar; 54(3):403-9. PubMed ID: 15736121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel coenzyme A:diacylglycerol acyltransferase 1 inhibitor stimulates lipid metabolism in muscle and lowers weight in animal models of obesity.
    Yamamoto T; Yamaguchi H; Miki H; Kitamura S; Nakada Y; Aicher TD; Pratt SA; Kato K
    Eur J Pharmacol; 2011 Jan; 650(2-3):663-72. PubMed ID: 21034741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of diacylglycerol acyltransferase: a review of 2008 patents.
    King AJ; Judd AS; Souers AJ
    Expert Opin Ther Pat; 2010 Jan; 20(1):19-29. PubMed ID: 20021283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure.
    Vaziri ND; Kim CH; Dang B; Zhan CD; Liang K
    Am J Physiol Renal Physiol; 2004 Jul; 287(1):F90-4. PubMed ID: 15010358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia, and hepatic steatosis in db/db mice.
    Zhang XD; Yan JW; Yan GR; Sun XY; Ji J; Li YM; Hu YH; Wang HY
    Acta Pharmacol Sin; 2010 Nov; 31(11):1470-7. PubMed ID: 21052084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat.
    Smith SJ; Cases S; Jensen DR; Chen HC; Sande E; Tow B; Sanan DA; Raber J; Eckel RH; Farese RV
    Nat Genet; 2000 May; 25(1):87-90. PubMed ID: 10802663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-hyperlipidemic and hypoglycemic effects of Gynostemma pentaphyllum in the Zucker fatty rat.
    Megalli S; Davies NM; Roufogalis BD
    J Pharm Pharm Sci; 2006; 9(3):281-91. PubMed ID: 17207412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coenzyme A: diacylglycerol acyltransferase 1 inhibitor ameliorates obesity, liver steatosis, and lipid metabolism abnormality in KKAy mice fed high-fat or high-carbohydrate diets.
    Yamamoto T; Yamaguchi H; Miki H; Shimada M; Nakada Y; Ogino M; Asano K; Aoki K; Tamura N; Masago M; Kato K
    Eur J Pharmacol; 2010 Aug; 640(1-3):243-9. PubMed ID: 20478303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of microsomal triglyceride transfer protein improves insulin sensitivity and reduces atherogenic risk in Zucker fatty rats.
    Dhote V; Joharapurkar A; Kshirsagar S; Dhanesha N; Patel V; Patel A; Raval S; Jain M
    Clin Exp Pharmacol Physiol; 2011 May; 38(5):338-44. PubMed ID: 21401695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of orally active carboxylic acid derivatives of 2-phenyl-5-trifluoromethyloxazole-4-carboxamide as potent diacylglycerol acyltransferase-1 inhibitors for the potential treatment of obesity and diabetes.
    Qian Y; Wertheimer SJ; Ahmad M; Cheung AW; Firooznia F; Hamilton MM; Hayden S; Li S; Marcopulos N; McDermott L; Tan J; Yun W; Guo L; Pamidimukkala A; Chen Y; Huang KS; Ramsey GB; Whittard T; Conde-Knape K; Taub R; Rondinone CM; Tilley J; Bolin D
    J Med Chem; 2011 Apr; 54(7):2433-46. PubMed ID: 21413799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a potent, selective, and orally efficacious pyrimidinooxazinyl bicyclooctaneacetic acid diacylglycerol acyltransferase-1 inhibitor.
    Birch AM; Birtles S; Buckett LK; Kemmitt PD; Smith GJ; Smith TJ; Turnbull AV; Wang SJ
    J Med Chem; 2009 Mar; 52(6):1558-68. PubMed ID: 19256504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice.
    Chen HC; Farese RV
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):482-6. PubMed ID: 15569818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of [trans-5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl]acetic acid monobenzenesulfonate (JTT-553), a novel acyl CoA:diacylglycerol transferase (DGAT) 1 inhibitor.
    Tomimoto D; Okuma C; Ishii Y; Akiyama Y; Ohta T; Kakutani M; Ohkuma Y; Ogawa N
    Biol Pharm Bull; 2015; 38(2):263-9. PubMed ID: 25747985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitor.
    Zhao G; Souers AJ; Voorbach M; Falls HD; Droz B; Brodjian S; Lau YY; Iyengar RR; Gao J; Judd AS; Wagaw SH; Ravn MM; Engstrom KM; Lynch JK; Mulhern MM; Freeman J; Dayton BD; Wang X; Grihalde N; Fry D; Beno DW; Marsh KC; Su Z; Diaz GJ; Collins CA; Sham H; Reilly RM; Brune ME; Kym PR
    J Med Chem; 2008 Feb; 51(3):380-3. PubMed ID: 18183944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sesquiterpenoids isolated from the flower buds of Tussilago farfara L. inhibit diacylglycerol acyltransferase.
    Park HR; Yoo MY; Seo JH; Kim IS; Kim NY; Kang JY; Cui L; Lee CS; Lee CH; Lee HS
    J Agric Food Chem; 2008 Nov; 56(22):10493-7. PubMed ID: 18937486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease.
    Choi SS; Diehl AM
    Curr Opin Lipidol; 2008 Jun; 19(3):295-300. PubMed ID: 18460922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of thiazole containing biaryl analogs as diacylglycerol acyltransferase 1 (DGAT1) inhibitors.
    Kadam KS; Jadhav RD; Kandre S; Guha T; Reddy MM; Brahma MK; Deshmukh NJ; Dixit A; Doshi L; Srinivasan S; Devle J; Damre A; Nemmani KV; Gupte A; Sharma R
    Eur J Med Chem; 2013 Jul; 65():337-47. PubMed ID: 23735282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel series of benzimidazole derivatives as diacylglycerol acyltransferase inhibitors.
    Lee K; Goo JI; Jung HY; Kim M; Boovanahalli SK; Park HR; Kim MO; Kim DH; Lee HS; Choi Y
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7456-60. PubMed ID: 23141914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.